Svetlana V. Starevskaia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Svetlana V. Starevskaia has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Dmitry Yurievich Ovsyannikov
RUDN University (Patrice Émery Lumumba People’s Friendship University of Russia), Moscow, Russia
5 shared publications - Irina O. Shmeleva
Saint Petersburg State Research Institute of Phthisiopulmonology
4 shared publications - Maxim A. Karpenko
Peoples’ Friendship University of Russia named after Patrice Lumumba
4 shared publications - Olga I. Simonova
National Medical Research Center for Children’s Health; Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications - Anna G. Tsverava
Morozov Children’s City Clinical Hospital
3 shared publications - Elina A. Nafanailova
Morozov Children’s City Clinical Hospital
3 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 3,p. 214-220
Idiopathic pulmonary hemosiderosis in children: results of a multicenter study
Background. Idiopathic pulmonary hemosiderosis (IPH) is a rare interstitial lung disease associated with recurrent diffuse alveolar hemorrhage, anemia, and the risk of pulmonary fibrosis. Aim. To describe the clinical and laboratory, computed tomographic, diagnostic, therapeutic characteristics and outcomes of children with IPH. Materials and methods. This ambispective descriptive multicenter study included 11 patients with disease onset before 18 years of age and pulmonary hemorrhage/hemosiderosis documented by bronchoscopy with bronchoalveolar lavage, cytological and/or morphological examination, after exclusion of alternative causes. Clinical history, laboratory and instrumental findings, treatment, and outcomes were evaluated. Results. The cohort included 5 boys and 6 girls. The median age at IPH onset was 6.0 [3.7; 8.6] years, the median age at diagnosis was 8.0 [4.9; 9.7] years, the median diagnostic delay was 4.9 [1.8; 22.8] months, and the median minimum hemoglobin level was 52 [38.5; 98.5] g/L (data available for 10 patients). Anemia was documented in all patients, and hemoptysis in 6/11 (55%). Signs of diffuse lung involvement on chest CT were present in all patients; ground-glass opacities and consolidation were the most common findings. Six patients required ICU care, 3 required mechanical ventilation, and 8 received red blood cell transfusions. All patients received systemic glucocorticoids; azathioprine was used in 5, rituximab in 4, and cyclophosphamide in 1 patient. Three patients died. Conclusion. IPH debuts anemia in children. The absence of hemoptysis does not exclude diffuse alveolar hemorrhage. Early computed tomography of the chest organs, bronchoscopy with bronchoalveolar lavage, the search for siderophages and the exclusion of secondary causes are the key stages of diagnosis. In severe and recurrent cases, multidisciplinary management and steroid-sparing immunosuppressive therapy are required.
- 14 October 2026
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 3,p. 214-220
Open AccessIdiopathic pulmonary hemosiderosis in children: results of a multicenter study
Background. Idiopathic pulmonary hemosiderosis (IPH) is a rare interstitial lung disease associated with recurrent diffuse alveolar hemorrhage, anemia, and the risk of pulmonary fibrosis. Aim. To describe the clinical and laboratory, computed tomographic, diagnostic, therapeutic characteristics and outcomes of children with IPH. Materials and methods. This ambispective descriptive multicenter study included 11 patients with disease onset before 18 years of age and pulmonary hemorrhage/hemosiderosis documented by bronchoscopy with bronchoalveolar lavage, cytological and/or morphological examination, after exclusion of alternative causes. Clinical history, laboratory and instrumental findings, treatment, and outcomes were evaluated. Results. The cohort included 5 boys and 6 girls. The median age at IPH onset was 6.0 [3.7; 8.6] years, the median age at diagnosis was 8.0 [4.9; 9.7] years, the median diagnostic delay was 4.9 [1.8; 22.8] months, and the median minimum hemoglobin level was 52 [38.5; 98.5] g/L (data available for 10 patients). Anemia was documented in all patients, and hemoptysis in 6/11 (55%). Signs of diffuse lung involvement on chest CT were present in all patients; ground-glass opacities and consolidation were the most common findings. Six patients required ICU care, 3 required mechanical ventilation, and 8 received red blood cell transfusions. All patients received systemic glucocorticoids; azathioprine was used in 5, rituximab in 4, and cyclophosphamide in 1 patient. Three patients died. Conclusion. IPH debuts anemia in children. The absence of hemoptysis does not exclude diffuse alveolar hemorrhage. Early computed tomography of the chest organs, bronchoscopy with bronchoalveolar lavage, the search for siderophages and the exclusion of secondary causes are the key stages of diagnosis. In severe and recurrent cases, multidisciplinary management and steroid-sparing immunosuppressive therapy are required.
- 12 October 2026
- Published by ECO-Vector LLC (Publications) in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 18 (3) , 89-96
The rare occurrence and severe consequences. Malformation of the lungs in a teenager — arteriovenous malformation of the lower lobe of the left lung
Arteriovenous malformation of the lungs is a congenital vascular anomaly characterized by the presence of a direct pathological connection between the branches of the pulmonary artery and the pulmonary veins, resulting in the formation of an intrapulmonary shunt from right to left and the shunting of unoxygenated blood into the arterial circulation. This lesion, first described by T. Churton in 1897, remains a relevant problem in modern thoracic surgery and pulmonology due to its rarity, the absence of pathognomonic symptoms, and the wide range of clinical manifestations — from asymptomatic course to life-threatening complications, including hemorrhagic events, paradoxical embolism, abscess, and cerebral infarction. Due to the rarity of the disease, the difficulty of its diagnosis, and the serious consequences of аrteriovenous malformation, we present our own observation of a rare case of the diagnosis and treatment of arteriovenous malformation of the lower lobe of the left lung in a teenager.
- 12 October 2026
- Published by ECO-Vector LLC (Publications) in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 18 (3) , 89-96
The rare occurrence and severe consequences. Malformation of the lungs in a teenager — arteriovenous malformation of the lower lobe of the left lung
Arteriovenous malformation of the lungs is a congenital vascular anomaly characterized by the presence of a direct pathological connection between the branches of the pulmonary artery and the pulmonary veins, resulting in the formation of an intrapulmonary shunt from right to left and the shunting of unoxygenated blood into the arterial circulation. This lesion, first described by T. Churton in 1897, remains a relevant problem in modern thoracic surgery and pulmonology due to its rarity, the absence of pathognomonic symptoms, and the wide range of clinical manifestations — from asymptomatic course to life-threatening complications, including hemorrhagic events, paradoxical embolism, abscess, and cerebral infarction. Due to the rarity of the disease, the difficulty of its diagnosis, and the serious consequences of аrteriovenous malformation, we present our own observation of a rare case of the diagnosis and treatment of arteriovenous malformation of the lower lobe of the left lung in a teenager.
- Open Access
- 27 April 2025
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 103 (2) , 102-110
Ways to Enhance the Diagnosis of Pulmonary Sarcoidosis (Literature Review)
The article analyzes 50 publications devoted to diagnostic approaches to detection of sarcoidosis. It highlights that currently diagnosis of this disease is not standardized and thus errors are highly possible to occur. Improved approaches address all aspects of diagnosis, from the distinction of highly specific clinical and radiologic signs of the disease to the choice of lung biopsy method. The use of sarcoidosis biomarkers such as angiotensin-converting enzyme, chitotriosidase, and serum amyloid A is most promising. The possibility of their combination and association with clinical signs of the disease are being studied, and to discover new biomarkers, full-genome studies are being in progress.
- 27 April 2025
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 103 (2) , 102-110
Open AccessWays to Enhance the Diagnosis of Pulmonary Sarcoidosis (Literature Review)
The article analyzes 50 publications devoted to diagnostic approaches to detection of sarcoidosis. It highlights that currently diagnosis of this disease is not standardized and thus errors are highly possible to occur. Improved approaches address all aspects of diagnosis, from the distinction of highly specific clinical and radiologic signs of the disease to the choice of lung biopsy method. The use of sarcoidosis biomarkers such as angiotensin-converting enzyme, chitotriosidase, and serum amyloid A is most promising. The possibility of their combination and association with clinical signs of the disease are being studied, and to discover new biomarkers, full-genome studies are being in progress.
- Open Access
- 1 November 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 3,p. 280-288
Primary ciliary dyskinesia in children: clinical, laboratory-instrumental and genetic characteristics
Background. Primary ciliary dyskinesia (PCD) is an orphan disease, and diagnosis is difficult because there is no gold standard for diagnosis. Aim. Clinical, laboratory-instrumental, genetic characteristics of PCD in children. Materials and methods. From 2009 to 2024, 31 patients with a genetically confirmed diagnosis of PCD were observed as part of a multicenter, open-ended, descriptive pilot longitudinal study. Examination methods: clinical and anamnestic method; X-ray examination and computed tomography of the chest organs and paranasal sinuses, tracheobronchoscopy; sputum/aspirate cultures of the tracheobroncheal tree with determination of sensitivity to antibiotics; transmission electron microscopy, high-speed video microscopy of the ciliated epithelium, cytological examination of bronchoalveolar lavage; monitoring computer pulse oximetry, echocardiography, audiometry, spirometry with bronchodilator test. Results. Respiratory symptoms in the neonatal period have 80% of children with PCD, lateralization defects – 35%, congenital heart defects – 13%, bronchiectasis – 68%, purulent endobronchitis – 62%, year-round rhinitis – 84%, hearing loss, otitis – 65%. The average age of onset of symptoms was 1 [1; 1] weeks, and the verification of diagnosis was 6 [2,5; 8] years. The main pathogens of chronic respiratory infection with PCD are Haemophilus influenzae, Pseudomonas aeruginosa, Staphylococcus aureus. The most common cause of PCD was biallelic variants of the DNAH5 gene. Conclusion. The diagnosis of PCD should be based on the application of the maximum number of diagnostic tests.
- 1 November 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 3,p. 280-288
Open AccessPrimary ciliary dyskinesia in children: clinical, laboratory-instrumental and genetic characteristics
Background. Primary ciliary dyskinesia (PCD) is an orphan disease, and diagnosis is difficult because there is no gold standard for diagnosis. Aim. Clinical, laboratory-instrumental, genetic characteristics of PCD in children. Materials and methods. From 2009 to 2024, 31 patients with a genetically confirmed diagnosis of PCD were observed as part of a multicenter, open-ended, descriptive pilot longitudinal study. Examination methods: clinical and anamnestic method; X-ray examination and computed tomography of the chest organs and paranasal sinuses, tracheobronchoscopy; sputum/aspirate cultures of the tracheobroncheal tree with determination of sensitivity to antibiotics; transmission electron microscopy, high-speed video microscopy of the ciliated epithelium, cytological examination of bronchoalveolar lavage; monitoring computer pulse oximetry, echocardiography, audiometry, spirometry with bronchodilator test. Results. Respiratory symptoms in the neonatal period have 80% of children with PCD, lateralization defects – 35%, congenital heart defects – 13%, bronchiectasis – 68%, purulent endobronchitis – 62%, year-round rhinitis – 84%, hearing loss, otitis – 65%. The average age of onset of symptoms was 1 [1; 1] weeks, and the verification of diagnosis was 6 [2,5; 8] years. The main pathogens of chronic respiratory infection with PCD are Haemophilus influenzae, Pseudomonas aeruginosa, Staphylococcus aureus. The most common cause of PCD was biallelic variants of the DNAH5 gene. Conclusion. The diagnosis of PCD should be based on the application of the maximum number of diagnostic tests.
- Open Access
- 16 September 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 280-288
Primary ciliary dyskinesia in children: clinical, laboratory-instrumental and genetic characteristics
Background. Primary ciliary dyskinesia (PCD) is an orphan disease, and diagnosis is difficult because there is no gold standard for diagnosis. Aim. Clinical, laboratory-instrumental, genetic characteristics of PCD in children. Materials and methods. From 2009 to 2024, 31 patients with a genetically confirmed diagnosis of PCD were observed as part of a multicenter, open-ended, descriptive pilot longitudinal study. Examination methods: clinical and anamnestic method; X-ray examination and computed tomography of the chest organs and paranasal sinuses, tracheobronchoscopy; sputum/aspirate cultures of the tracheobroncheal tree with determination of sensitivity to antibiotics; transmission electron microscopy, high-speed video microscopy of the ciliated epithelium, cytological examination of bronchoalveolar lavage; monitoring computer pulse oximetry, echocardiography, audiometry, spirometry with bronchodilator test. Results. Respiratory symptoms in the neonatal period have 80% of children with PCD, lateralization defects – 35%, congenital heart defects – 13%, bronchiectasis – 68%, purulent endobronchitis – 62%, year-round rhinitis – 84%, hearing loss, otitis – 65%. The average age of onset of symptoms was 1 [1; 1] weeks, and the verification of diagnosis was 6 [2,5; 8] years. The main pathogens of chronic respiratory infection with PCD are Haemophilus influenzae, Pseudomonas aeruginosa, Staphylococcus aureus. The most common cause of PCD was biallelic variants of the DNAH5 gene. Conclusion. The diagnosis of PCD should be based on the application of the maximum number of diagnostic tests.
- 16 September 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 280-288
Open AccessPrimary ciliary dyskinesia in children: clinical, laboratory-instrumental and genetic characteristics
Background. Primary ciliary dyskinesia (PCD) is an orphan disease, and diagnosis is difficult because there is no gold standard for diagnosis. Aim. Clinical, laboratory-instrumental, genetic characteristics of PCD in children. Materials and methods. From 2009 to 2024, 31 patients with a genetically confirmed diagnosis of PCD were observed as part of a multicenter, open-ended, descriptive pilot longitudinal study. Examination methods: clinical and anamnestic method; X-ray examination and computed tomography of the chest organs and paranasal sinuses, tracheobronchoscopy; sputum/aspirate cultures of the tracheobroncheal tree with determination of sensitivity to antibiotics; transmission electron microscopy, high-speed video microscopy of the ciliated epithelium, cytological examination of bronchoalveolar lavage; monitoring computer pulse oximetry, echocardiography, audiometry, spirometry with bronchodilator test. Results. Respiratory symptoms in the neonatal period have 80% of children with PCD, lateralization defects – 35%, congenital heart defects – 13%, bronchiectasis – 68%, purulent endobronchitis – 62%, year-round rhinitis – 84%, hearing loss, otitis – 65%. The average age of onset of symptoms was 1 [1; 1] weeks, and the verification of diagnosis was 6 [2,5; 8] years. The main pathogens of chronic respiratory infection with PCD are Haemophilus influenzae, Pseudomonas aeruginosa, Staphylococcus aureus. The most common cause of PCD was biallelic variants of the DNAH5 gene. Conclusion. The diagnosis of PCD should be based on the application of the maximum number of diagnostic tests.
- Open Access
- 9 April 2024
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 15 (1) , 111-115
Clinical case of pulmonary alveolar proteinosis in a newborn
Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the accumulation of protein-lipid complexes in the alveoli due to impaired utilization of surfactant by alveolar macrophages; it is most often idiopathic and occurs in healthy men and women aged 30–50 years. The congenital form of PAP is extremely rare, its diagnosis is complicated by the fact that it is impossible to conduct functional lung tests in newborns, and lung biopsy is used extremely rarely. Against this background, data obtained by computed tomography (CT) of the lungs of newborns are of particular importance. The article presents a clinical case of treatment of a newborn with respiratory failure (RF) and signs of pulmonary hypertension, who was admitted to the neonatal intensive care unit of the Children’s City Multidisciplinary Clinical Specialized Center for High Medical Technologies at the age of the first day of life. The article reflects the role of computed tomography in diagnosing the causes of respiratory failure in newborns, as well as the importance of anamnesis and a thorough clinical examination of patients. The presented clinical case demonstrates the need for a multidisciplinary approach to the diagnosis of newborns with pulmonary alveolar proteinosis.
- 9 April 2024
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 15 (1) , 111-115
Open AccessClinical case of pulmonary alveolar proteinosis in a newborn
Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the accumulation of protein-lipid complexes in the alveoli due to impaired utilization of surfactant by alveolar macrophages; it is most often idiopathic and occurs in healthy men and women aged 30–50 years. The congenital form of PAP is extremely rare, its diagnosis is complicated by the fact that it is impossible to conduct functional lung tests in newborns, and lung biopsy is used extremely rarely. Against this background, data obtained by computed tomography (CT) of the lungs of newborns are of particular importance. The article presents a clinical case of treatment of a newborn with respiratory failure (RF) and signs of pulmonary hypertension, who was admitted to the neonatal intensive care unit of the Children’s City Multidisciplinary Clinical Specialized Center for High Medical Technologies at the age of the first day of life. The article reflects the role of computed tomography in diagnosing the causes of respiratory failure in newborns, as well as the importance of anamnesis and a thorough clinical examination of patients. The presented clinical case demonstrates the need for a multidisciplinary approach to the diagnosis of newborns with pulmonary alveolar proteinosis.
- Open Access
- 18 January 2024
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 1,p. 159-164
Pathology of the respiratory system in children with Down syndrome
Down’s syndrome is the most frequent chromosomal abnormality. According to the literature, respiratory diseases are the most frequent reasons of hospitalization of children with Down’s syndrome. Also, respiratory diseases are diagnosed for 42% of patients with Down’s syndrome during first two years of life. Objective. Objective is to define features of respiratory diseases course for children with Down’s syndrome to determine the best cure tactics. Materials and methods. Six patients with Down’s syndrome and damage to respiratory system at age of from 2 month to 7 years were under observation. Medical documentation, anamnesis data, CT scan of the thorax organs and objective examination data has been analyzed. Results. Abnormal pregnancy has been confirmed for 4 patients, 50% of patients had been born premature. Congenital heart defects had been diagnosed for 5 patients. Four patients suffered lower respiratory tract diseases with respiratory failure at an early age, cure in intensive care unit or pulmonary department has been required. Later recurrent respiratory diseases were observed. One patient was referred to a pulmonologist by a doctor of another specialty in early childhood. Shortness of breath of mixed or insular type, cough, cyanosis, night apnea, physically observed strengthening wheezing during respiratory infections, for 4 patients - mosaic performance of breathing has been clinically recorded. According to the results of the X-ray examination, the changes are - «ground-glass opacity» - 5 patients, subpleural cysts - 4 patients, uneven ventilation - all. Two patients have radiological evidence of lymphoid interstitial pneumonitis. subsequently all patients were observed by a pulmonologist, prescribed pathogenetic treatment with inhalation glucocorticostroids, and two children received systemic glucocorticosteroids with positive effects. The X-ray dynamics showed a regression of alveolar infiltration for 6-9 months, as well as a decrease in shortness of breath, an improvement in physical activity tolerance, objectively - no strengthening wheezing by four years for 4 patients. Conclusion. Children with Down’s syndrome and respiratory failure from an early age require specialized pulmonological care. Timely diagnosis and optimal therapeutic strategies are critical to ensure treatment outcomes.
- 18 January 2024
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 1,p. 159-164
Open AccessPathology of the respiratory system in children with Down syndrome
Down’s syndrome is the most frequent chromosomal abnormality. According to the literature, respiratory diseases are the most frequent reasons of hospitalization of children with Down’s syndrome. Also, respiratory diseases are diagnosed for 42% of patients with Down’s syndrome during first two years of life. Objective. Objective is to define features of respiratory diseases course for children with Down’s syndrome to determine the best cure tactics. Materials and methods. Six patients with Down’s syndrome and damage to respiratory system at age of from 2 month to 7 years were under observation. Medical documentation, anamnesis data, CT scan of the thorax organs and objective examination data has been analyzed. Results. Abnormal pregnancy has been confirmed for 4 patients, 50% of patients had been born premature. Congenital heart defects had been diagnosed for 5 patients. Four patients suffered lower respiratory tract diseases with respiratory failure at an early age, cure in intensive care unit or pulmonary department has been required. Later recurrent respiratory diseases were observed. One patient was referred to a pulmonologist by a doctor of another specialty in early childhood. Shortness of breath of mixed or insular type, cough, cyanosis, night apnea, physically observed strengthening wheezing during respiratory infections, for 4 patients - mosaic performance of breathing has been clinically recorded. According to the results of the X-ray examination, the changes are - «ground-glass opacity» - 5 patients, subpleural cysts - 4 patients, uneven ventilation - all. Two patients have radiological evidence of lymphoid interstitial pneumonitis. subsequently all patients were observed by a pulmonologist, prescribed pathogenetic treatment with inhalation glucocorticostroids, and two children received systemic glucocorticosteroids with positive effects. The X-ray dynamics showed a regression of alveolar infiltration for 6-9 months, as well as a decrease in shortness of breath, an improvement in physical activity tolerance, objectively - no strengthening wheezing by four years for 4 patients. Conclusion. Children with Down’s syndrome and respiratory failure from an early age require specialized pulmonological care. Timely diagnosis and optimal therapeutic strategies are critical to ensure treatment outcomes.
- 19 August 2022
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 101 (4)
COMPUTED TOMOGRAPHY SEMIOTICS OF NEUROENDOCRINE CELLULAR HYPERPLASIA IN INFANTS: CLINICAL AND RADIOLOGICAL COMPARISONS
The neuroendocrine cell hyperplasia of infancy (NEHI) is an interstitial lung disease (ILD) of an unknown etiology that manifests itself in children of the first year of life and is characterized by the presence of persistent tachypnea of infancy (PTI) syndrome and nonspecific changes in lung biopsy in the form of hyperplasia of bombesin-positive neuroendocrine cells of the peripheral respiratory tract diagnosed in typical cases based on computed tomography (CT) of the lungs. The purpose of the study was to characterize the CT picture of NEHI in comparison with the severity of the disease. Materials and methods of the study: a multicenter observational cross-sectional study that was maintained January, 2012 March, 2022 portraying 83 patients with NEHI using the NEHI clinical diagnostic scale, ILD severity scale, pulse oximetry, chest CT and echocardiography. Results: CT-semiotics of NEHI is characterized by ground-glass opacification in 97% of cases with predominant localization in the middle lobe of the right lung (89%), upper lobe of the right lung (74%), in the upper lobe of the left lung (72%) and lingual segments (68%) with a prevalence in most cases not exceeding 25% of the total area of the lung fields on sections in the axial projection; parenchymal changes in the form of linear and reticular shading (4%), consolidation (15%), a symptom of “mosaic pneumatization” (35%); and thickening of the walls of the bronchi (28%). Based on the sum of scores on the clinical scale for diagnosing of NEHI, it is impossible to predict the prevalence of CT changes (Rs=0.12, p=0.5), whilst the severity of NEHI does not statistically significantly depend on the ground glass opacification area (Rs=0 .27, p=0.13). Conclusion: The most common CT-identified symptoms of NEHI are the symptoms of ground glass and “mosaic pneumatization” as well as the thickening of the bronchial walls.
- 19 August 2022
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 101 (4)
COMPUTED TOMOGRAPHY SEMIOTICS OF NEUROENDOCRINE CELLULAR HYPERPLASIA IN INFANTS: CLINICAL AND RADIOLOGICAL COMPARISONS
The neuroendocrine cell hyperplasia of infancy (NEHI) is an interstitial lung disease (ILD) of an unknown etiology that manifests itself in children of the first year of life and is characterized by the presence of persistent tachypnea of infancy (PTI) syndrome and nonspecific changes in lung biopsy in the form of hyperplasia of bombesin-positive neuroendocrine cells of the peripheral respiratory tract diagnosed in typical cases based on computed tomography (CT) of the lungs. The purpose of the study was to characterize the CT picture of NEHI in comparison with the severity of the disease. Materials and methods of the study: a multicenter observational cross-sectional study that was maintained January, 2012 March, 2022 portraying 83 patients with NEHI using the NEHI clinical diagnostic scale, ILD severity scale, pulse oximetry, chest CT and echocardiography. Results: CT-semiotics of NEHI is characterized by ground-glass opacification in 97% of cases with predominant localization in the middle lobe of the right lung (89%), upper lobe of the right lung (74%), in the upper lobe of the left lung (72%) and lingual segments (68%) with a prevalence in most cases not exceeding 25% of the total area of the lung fields on sections in the axial projection; parenchymal changes in the form of linear and reticular shading (4%), consolidation (15%), a symptom of “mosaic pneumatization” (35%); and thickening of the walls of the bronchi (28%). Based on the sum of scores on the clinical scale for diagnosing of NEHI, it is impossible to predict the prevalence of CT changes (Rs=0.12, p=0.5), whilst the severity of NEHI does not statistically significantly depend on the ground glass opacification area (Rs=0 .27, p=0.13). Conclusion: The most common CT-identified symptoms of NEHI are the symptoms of ground glass and “mosaic pneumatization” as well as the thickening of the bronchial walls.
- 18 February 2022
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 101 (1)
CLINICAL DIAGNOSIS SCALE FOR NEUROENDOCRINE CELL HYPERPLASIA IN INFANTS: INFORMATIVENESS AND DIFFERENTIAL DIAGNOSTIC SIGNIFICANCE
Neuroendocrine cell hyperplasia of infancy (NEHI) is an interstitial lung disease of unknown etiology that develops in the first year of life and manifests itself as persistent tachypnea syndrome. The aim of the study was to determine the diagnostic value of the clinical scale for the diagnosis of NEHI in comparison with computed tomography (CT) data of the chest organs and for differential diagnosis with acute bronchiolitis (AB)/community-acquired pneumonia (CAP). Materials and methods of research: a multicenter case-control study of children aged 21 days of life to 12 months was carried out: – 83 children with NEHI and 83 infants with AB or CAP. To determine the sensitivity and specificity of this scale for differential diagnosis with AB/CAP, the results of the assessment according to the proposed scale were compared in patients with NEHI (study group) and patients with AB/CAP (control group) on the day of treatment and after 3 weeks. Results: the sensitivity of the clinical scale for the diagnosis of NEHI when compared with the CT data of the chest organs was 85.5%. In the differential diagnosis of NEHI with AB/CAP on the day of treatment, the sensitivity of the clinical scale for the diagnosis of NEHI was 85.5%, the specificity was 80.7%; when re-evaluated after 3 weeks, the accuracy of the scale increased from 83.1% to 91.6%, the specificity – from 80.7% to 97.6%. Diagnosis on a scale after 3 weeks reduced the possibility of overdiagnosis of NEHI from 19.3% to 2.4%. Conclusions: the clinical scale for the diagnosis of NEHI has a high diagnostic value in comparison with the results of CT scan of the chest organs and for differential diagnosis with AB/CAP, especially when re-evaluating.
- 18 February 2022
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 101 (1)
CLINICAL DIAGNOSIS SCALE FOR NEUROENDOCRINE CELL HYPERPLASIA IN INFANTS: INFORMATIVENESS AND DIFFERENTIAL DIAGNOSTIC SIGNIFICANCE
Neuroendocrine cell hyperplasia of infancy (NEHI) is an interstitial lung disease of unknown etiology that develops in the first year of life and manifests itself as persistent tachypnea syndrome. The aim of the study was to determine the diagnostic value of the clinical scale for the diagnosis of NEHI in comparison with computed tomography (CT) data of the chest organs and for differential diagnosis with acute bronchiolitis (AB)/community-acquired pneumonia (CAP). Materials and methods of research: a multicenter case-control study of children aged 21 days of life to 12 months was carried out: – 83 children with NEHI and 83 infants with AB or CAP. To determine the sensitivity and specificity of this scale for differential diagnosis with AB/CAP, the results of the assessment according to the proposed scale were compared in patients with NEHI (study group) and patients with AB/CAP (control group) on the day of treatment and after 3 weeks. Results: the sensitivity of the clinical scale for the diagnosis of NEHI when compared with the CT data of the chest organs was 85.5%. In the differential diagnosis of NEHI with AB/CAP on the day of treatment, the sensitivity of the clinical scale for the diagnosis of NEHI was 85.5%, the specificity was 80.7%; when re-evaluated after 3 weeks, the accuracy of the scale increased from 83.1% to 91.6%, the specificity – from 80.7% to 97.6%. Diagnosis on a scale after 3 weeks reduced the possibility of overdiagnosis of NEHI from 19.3% to 2.4%. Conclusions: the clinical scale for the diagnosis of NEHI has a high diagnostic value in comparison with the results of CT scan of the chest organs and for differential diagnosis with AB/CAP, especially when re-evaluating.
- Open Access
- 20 January 2022
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 12 (4) , 99-104
Involvement of the respiratory organs in Crohn’s disease. A clinical case
Introduction. Crohn’s disease is a recurrent inflammatory disease that can affect any part of the gastrointestinal tract with transmural manifestations. Extraintestinal manifestations occur in 21–47% of all cases. Radiology techniques play a significant role in diagnosis, assessment and observation by means of computed tomography and magnetic resonance imaging.Materials and methods. Clinical data, laboratory and instrumental studies, surgical procedures done in the children’s hospital were collected and analyzed during the study.Results. A 4-year-old girl was urgently presented to the hospital with non-productive cough and tachypnea that had lasted for two days. Inhalation therapy with Berodual® and Pulmicort® was initiated with a minor effect. Chest multidetector computed tomography (MDCT) showed signs of larynx edema, regular bilateral infiltrates with a volume decrease of the lung on the right side, left-sided tension pneumothorax. It was known that Crohn’s disease had been diagnosed in 7 months. The condition of the child was assessed as a serious case of Crohn’s disease. The condition of patient became stable after 7 days of treatment. The child has been observed by a gastroenterologist and a pulmonologist later.Conclusion. It is highly recommended to take into account the possibility of respiratory system involvement in patients with diagnosed inflammatory bowel diseases. A thorough anamnestic data research and multidisciplinary approach while evaluating the results of the chest MDCT would help clinicians to optimize clinical management at the early stage of the disease and prevent the development of possible complications.
- 20 January 2022
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 12 (4) , 99-104
Open AccessInvolvement of the respiratory organs in Crohn’s disease. A clinical case
Introduction. Crohn’s disease is a recurrent inflammatory disease that can affect any part of the gastrointestinal tract with transmural manifestations. Extraintestinal manifestations occur in 21–47% of all cases. Radiology techniques play a significant role in diagnosis, assessment and observation by means of computed tomography and magnetic resonance imaging.Materials and methods. Clinical data, laboratory and instrumental studies, surgical procedures done in the children’s hospital were collected and analyzed during the study.Results. A 4-year-old girl was urgently presented to the hospital with non-productive cough and tachypnea that had lasted for two days. Inhalation therapy with Berodual® and Pulmicort® was initiated with a minor effect. Chest multidetector computed tomography (MDCT) showed signs of larynx edema, regular bilateral infiltrates with a volume decrease of the lung on the right side, left-sided tension pneumothorax. It was known that Crohn’s disease had been diagnosed in 7 months. The condition of the child was assessed as a serious case of Crohn’s disease. The condition of patient became stable after 7 days of treatment. The child has been observed by a gastroenterologist and a pulmonologist later.Conclusion. It is highly recommended to take into account the possibility of respiratory system involvement in patients with diagnosed inflammatory bowel diseases. A thorough anamnestic data research and multidisciplinary approach while evaluating the results of the chest MDCT would help clinicians to optimize clinical management at the early stage of the disease and prevent the development of possible complications.